Return to MD Anderson Cancer Center

Return to Department of Thoracic and Cardiovascular Surgery

What's New
Faculty & Staff
  Ara Vaporciyan , M.D.
    Curriculum Vitae
Education
Specific Diseases
Videos
Research
F.A.Q.
Glossary of Terms
Web Links
Thoracic Center
Contact Information

 

 

Curriculum Vitae - Ara Vaporciyan, M.D.


Academic and Professional Appointments:

2002-present, Director, Cardiac & Vascular Surgical Oncology Program, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

1998 - present, Assistant Professor and Assistant Surgeon, Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Back to Top


Editorships and Editorial Board Memberships:

Adhoc reviews:

  • Asian Cardiovascular & Thoracic Annals, 2000

Back to Top


Lectureships and Visiting Professorships:

Back to Top


Honors and Awards:

  • Outstanding Surgical Resident Award, The University of Texas, M. D. Anderson Cancer Center, 1996


Back to Top


Society Memberships and Offices Held:

  • Member, Southern Thoracic Surgical Association, 2001-Present
  • Candidate, Society of Thoracic Surgeons, 2000-Present
  • Member, American Thoracic Society, 1999-Present
  • Member, Cooley Hands, 1998-Present
  • Member, Denton A Cooley Cardiovascular Surgical Society, 1996-Present
  • Back to Top


Bibliography:

Published and accepted articles in refereed journals

Published and accepted invited journal articles

Published and accepted book chapters

Back to Top


Institutional Service Responsibilities and Other Duties:

Alternate Member,Medical Practice Subcommittee 2001 - present

Member, Medical Records Subcommittee, 2001 - present

Back to Top


Formal Teaching Experience:

Courses taught:

  • PECAM-1 (CD31, endoCAM) is involved in neutrophil recruitment in vivo, Trauma and Immune Consequences, Munich, Germany, 4/94.
  • Research during surgical residency, The University of Texas Medical School-Houston, General Surgery Pathophysiology Lecture, 9/98.
  • Multimodality therapy in esophageal cancer, Baylor College of Medicine, Pathophysiology Lecture Series, 10/98.
  • Surgical treatment in lung cancer: examining the role of multimodality therapy, Grand Rounds, Methodist Hospital Cancer Center, Lubbock, TX, 3/00.
  • Multi-modality approach to non-small cell lung cancer, Grand Rounds, Bristol-Myers Squibb, Texas Tech Health Science Center, Lubbock, TX, 6/00.
  • The surgical management of lung cancer". Oncology Visiting Faculty Program, Christus St. Francis Cabrini Hospital, Alexandria, LA , 6/00.
  • Innovative multidisciplinary approaches for lung cancer, Grand Rounds, McLaren Regional Medical Center, Flint, MI, 9/00.
  • Surgical treatment of lung cancer, Surgical Oncology Fellows Conference, The University of Texas - M. D. Anderson Cancer Center, Houston, TX, 11/00.
  • Early detection and multi-modality treatment of lung cancer, Bristol-Myers Squibb Oncology Visiting Faculty Program, Le Lavandier, Macon, GA, 12/00.
  • Isolated pulmonary nodules: management and intra-operative decision making, Advances in Oncology Institutional Grand Rounds, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 12/00.
  • Atelectasis/postoperative atelectasis and pleural effusion, Presented to the Department of Coding, The University of Texas M. D. Anderson Cancer Center, Houston, TX 04/01.
  • Chapter 33-34 of Glenn's Textbook, Chest Wall Abnormalities, Chest Wall Tumors, Baylor Cardiothoracic Surgery Lecture Series, Houston, Texas 12/01.
  • Lung cancer screening, Surgical Oncology Fellows Conference, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 01/02.
  • Rodent model of post-operative lung injury, Lung Injury Study Group, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 3/02.

Back to Top


Invitations to National or International Conferences:

  1. Rapid determination of neutrophil/endothelial adhesions in vitro using fluorescent labeling of cells, FASEB, 4/92.
  2. Impact of operative volume on morbidity, mortality and hospital usage following esophagectomy for esophageal cancer, Western Thoracic Surgical Association, Olympic Valley, CA, 6/99.
  3. Characterization of acute lung injury after isolated lung perfusion with doxorubicin, ACCP, American College of Chest Physician, San Francisco, CA, 10/00.
  4. Impact of timing of smoking cessation on pulmonary morbidity after pneumonectomy. 47th Annual Meeting of the Southern Thoracic Surgical Association, Marco Island, FL, 11/00.
  5. Early screening techniques for lung cancer. 1st Annual Oncology Update: Advances and Controversies, Steamboat Springs, CO, 2/01.
  6. Use of cardiopulmonary bypass for resection of advanced cardiothoracic malignancies. 15th Annual Meeting of the European Association for Cardio-Thoracic Surgeons, Lisbon, Portugal, 09/01.
  7. Neutrophil depletion reduces lung injury after iIsolated lung perfusion for pulmonary metastasis. 87th Clinical Congress of the American College of Surgeons, New Orleans, LA, 10/01.
  8. Perfluorocarbon improves adenoviral-mediated transfection of lung cancer cell lines via cell mediated effects. 2001 AACR-NCI-EORTC International Conference on Molecular Cancer Therapeutics, Miami Beach, FL, 11/01.
  9. Current advances in lung and esophageal cancer. Congress of the Slovenian Association of Surgeons, Hoteli Marje, Portorož, 05/02.

Back to Top


Other Activities:

Local presentations:

 

Back to Top